Global biopharma industry spending on temperature-controlled products is expected to reach $15.7 billion in 2019. To ensure that companies are able to navigate this new product landscape and complex routes in a cost efficient and effective way, they must rely on specialised and trusted partners.
In this report, Pharma IQ reached out to pharmaceutical manufacturers, medical device manufactures and logistics
providers to discover what industry trends that will affect temperature control
and logistics spending in the next 12 to 24 months.
Please note: That all fields marked with an asterisk (*) are required.